Non-selective inhibition of histone deacetylases (HDACs), enzymes that remove acetyl groups from histone core proteins, enhances cognition and NMDAR-dependent long-term potentiation at hippocampal CA3-CA1 synapses. It is not known whether this is a general mechanism by which HDACs modulate plasticity at other hippocampal synapses. Furthermore, it has yet to be tested whether HDAC inhibition can reverse deficits in synaptic plasticity in disease models. Here, we investigated whether inhibition of HDACs, and specifically HDAC3, a class I HDAC isoform known to negatively regulate hippocampusdependent learning and memory, enhances LTP at medial perforant path-dentate granule cell (MPP-DGC) synapses in wild-type and Fragile X (Fmr1-/y) mice, a model with known LTP deficits at this synapse. The non-selective HDAC inhibitor trichostatin A (TSA) significantly increased the magnitude of LTP at MPP-DGC synapses in wild-type mice, similar to reports at CA3-CA1 synapses. The enhancement of LTP was mimicked by selective HDAC3 inhibition, implicating a role for this isoform in the negative regulation of synaptic plasticity. However, HDAC3 inhibition was completely ineffective in reversing the deficit in LTP at MPP-DGC synapses in slices from Fmr1-/y mice, and in fact, HDAC3 inhibition was unable to induce any improvement whatsoever. These findings indicate that the enhancing effect of HDAC3 inhibition on LTP in wild-type mice requires FMRP, revealing a novel role for FMRP in hippocampal plasticity.
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Introduction
Histone deacetylases (HDACs), enzymes that encourage chromatin condensation by removing acetyl groups from histones, decrease transcription of genes required for memory formation (Kouzarides, 2007) . Previous studies demonstrated that nonselective HDAC inhibition enhances NMDAR-dependent long-term potentiation (LTP) at hippocampal CA3-CA1 synapses and hippocampus-dependent learning and memory in wild-type (WT) mice (Levenson et al., 2004; Stefanko, Barrett, Ly, Reolon, & Wood, 2009; Vecsey et al., 2007) . HDAC inhibition also improves learning and memory in an Alzheimer's disease mouse model and in mice with p25-induced neurodegeneration (Fischer, Sananbenesi, Wang, Dobbin, & Tsai, 2007; Kilgore et al., 2010) . Although these findings support the therapeutic potential of HDAC inhibitors in treating cognitive deficiencies, their non-specific effects limit clinical use (Bruserud, Stapnes, Ersvaer, Gjertsen, & Ryningen, 2007; Renthal et al., 2007; Tsankova et al., 2006) , motivating studies to determine which HDAC isoforms can be selectively targeted to improve memory function.
To-date, three Class I HDAC isoforms have been investigated and two have been identified as negative regulators of memory formation. Over-expression of HDAC2, but not HDAC1, impairs LTP at CA3-CA1 synapses associated with deficits in contextual fear conditioning and Morris water maze, while synaptic plasticity and memory are facilitated in HDAC2 knockout mice (Guan et al., 2009) . Genetic deletion or selective pharmacological inhibition of HDAC3, the isoform most highly expressed in hippocampus (Broide et al., 2007) , enhances object recognition and location memory (McQuown et al., 2011) , but whether the behavioral improvements are associated with increased LTP was not explored.
The beneficial effects of HDAC inhibition on synaptic plasticity have been studied primarily at hippocampal CA3-CA1 synapses in WT mice. Therefore, it is not known whether HDAC inhibitors
